epirubicin has been researched along with Hepatic Encephalopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, H; Guo, H; Hao, K; Jiang, W; Su, D; Xu, H | 1 |
Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS | 1 |
2 other study(ies) available for epirubicin and Hepatic Encephalopathy
Article | Year |
---|---|
Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Carrier Proteins; Cognitive Dysfunction; Cytokines; Epirubicin; Hepatic Encephalopathy; Hippocampus; Male; Malondialdehyde; Memory; Mice, Inbred BALB C; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Saponins; Spatial Learning; Superoxide Dismutase; Thioredoxins; Triterpenes | 2019 |
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Iodized Oil; Liver Failure; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pulmonary Embolism; Young Adult | 2008 |